The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

JSON

Eriksson A, Hermanson M, Wickström M, Lindhagen E, Ekholm C, Jenmalm Jensen A, Löthgren A, Lehmann F, Larsson R, Parrow V, Höglund M

Blood Cancer J 2 (8) e81 [2012-08-00; online 2012-08-00]

Chemical Biology Consortium Sweden (CBCS) [Collaborative]

PubMed 22864397

DOI 10.1038/bcj.2012.28

Crossref 10.1038/bcj.2012.28